Company China Pharma Holdings, Inc. OTC Bulletin Board
Equities
US16941T1043
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 8 | 100.0 % | 7 | 100.0 % | -13.48% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 8 | 100.0 % | 7 | 100.0 % | -13.48% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Lin Li
CEO | Chief Executive Officer | 71 | 28/99/28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Lin Li
CEO | Chief Executive Officer | 71 | 28/99/28 |
Gene Bennett
BRD | Director/Board Member | 76 | 01/08/01 |
Heung Mei Tsui
BRD | Director/Board Member | 67 | 28/09/28 |
Ying Wen Zhang
BRD | Director/Board Member | 79 | 01/08/01 |
Bao Wen Dong
BRD | Director/Board Member | 83 | 01/08/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,870,070 | 5,997,830 ( 37.79 %) | 0 | 37.79 % |
Company contact information
China Pharma Holdings, Inc.
No.17, Jinpan Road 2nd Floor
570216, Haikou
+
http://www.chinapharmaholdings.com![address China Pharma Holdings, Inc.](https://cdn.zonebourse.com/static/address/179233.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+62.66% | 841B | |
+40.42% | 625B | |
-4.37% | 360B | |
+17.16% | 327B | |
+9.87% | 300B | |
+15.66% | 242B | |
+17.90% | 227B | |
+14.86% | 174B | |
+0.45% | 162B |